Skip to main content

Provider

By Jessica Hagen | 01:30 pm | July 26, 2024
Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.
By Nathan Eddy | 01:32 pm | July 25, 2024
The platform includes language support, call-to-text functionality, a high degree of automation and community outreach features.
By Jessica Hagen | 06:37 pm | July 24, 2024
The tech giant, UW School of Medicine and Public Health, Mass General Brigham and UW Health will develop multimodal AI foundation models utilizing Azure and Nuance.
HIMSS24
By HIMSS TV | 05:09 pm | July 24, 2024
Amid the trend of healthcare companies leveraging AI, Jerry Villacres, Manifold's VP of Sales, Cloud Solutions, cautions that they must first implement a sound data strategy to make the most out of those tools.
By Jessica Hagen | 02:47 pm | July 24, 2024
The company's first feature to emerge is its "smart notes." It generates clinical notes for providers based on conversations with Talkspace members.
HIMSS24
By HIMSS TV | 07:00 am | July 24, 2024
Mark Polyak, president of global data management at IPSOS, says LLMs can "talk" to patients about administrative tasks like scheduling, but bias and model compatibility must be addressed before clinical deployments.  
By HIMSS TV | 06:26 pm | July 23, 2024
Harvard research associate Brian Spisak discusses how a "leadership-first, tech-last" approach can prevent organisations from deploying ticking time bombs.  
By Jessica Hagen | 03:37 pm | July 23, 2024
The funding comes less than a year after the virtual mental health company closed a $125 million Series C funding round.
By Jessica Hagen | 02:15 pm | July 23, 2024
The three companies will collaborate with Mayo Clinic nurses to create a genAI documentation workflow tool that will integrate into Epic nursing workflows.
By HIMSS TV | 07:00 am | July 23, 2024
Michael Pace, founder and president of PalmHealthCo, highlights how his company advises organizations, including pharma, in commercialization and go-to-market strategies for digital therapeutics - and his experience at Pear Therapeutics.